Understanding brain health effects from metals in e-cigarette vapor
Neurotoxic and neurodegenerative risks from chronic exposure to metal mixtures in e-cigarette aerosol
This work looks at how metals found in e-cigarette vapor might affect brain health, especially for young people who use them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11134740 on NIH RePORTER |
What this research studies
Many people, especially younger individuals, are using e-cigarettes, but we don't fully understand their long-term health effects. This project focuses on concerns that certain metals released from e-cigarette heating coils could build up in the brain. Researchers want to find out if these metals might lead to brain damage or increase the chance of developing neurodegenerative diseases over time. The team will measure metal levels in e-cigarette vapor and explore their potential impact on brain cells.
Who could benefit from this research
Good fit: This research is relevant to current or past e-cigarette users, particularly adolescents and young adults, who are concerned about potential neurotoxic effects.
Not a fit: Patients who have never used e-cigarettes or are not concerned about neurodegenerative conditions may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could help us understand the long-term brain health effects of e-cigarette use and inform public health guidelines to protect users.
How similar studies have performed: While e-cigarette risks for other conditions are being explored, the specific link between e-cigarette metals and neurodegenerative diseases is a newer area of concern that this work aims to clarify.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Re, Diane Berengere — Columbia University Health Sciences
- Study coordinator: Re, Diane Berengere
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.